(Q34088740)

30 July 2017

1 reference

title

The psychopharmacology of tachykinin NK-3 receptors in laboratory animals (English)

1 reference

30 July 2017

0 references

M Massi

1

1 reference

PubMed ID

11090913

30 July 2017

I Panocka

series ordinal

2

1 reference

PubMed ID

11090913

30 July 2017

G de Caro

series ordinal

3

1 reference

30 July 2017

1 November 2000

1 reference

30 July 2017

13

1 reference

inferred from page(s)

published in

Peptides

1 reference

30 July 2017

21

1 reference

30 July 2017

1597-1609

1 reference

30 July 2017

11

1 reference

The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Substance P antagonists: the next breakthrough in treating depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Presence of NK3-sensitive neurones in different proportions in the medial habenula of guinea-pig, rat and gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

A cDNA encoding the precursor of the rat neuropeptide, neurokinin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Molecular characterisation, expression and localisation of human neurokinin‐3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Substance P excitation of rat locus coeruleus neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Mesencephalic dopaminergic neurons expressing neuromedin K receptor (NK3): a double immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Antidepressant-like effect of ethanol revealed in the forced swimming test in Sardinian alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Subcutaneous injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

ESBRA-Nordmann 1996 Award Lecture: ethanol drinking behaviour in Sardinian alcohol-preferring rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Sardinian alcohol-preferring rats: a genetic animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The distribution of substance P immunoreactive fibers in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Central tachykinins: mediators of defence reaction and stress reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Influence of naloxone on antidepressant drug effects in the forced swimming test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Serotonin is reduced in the frontal cortex of Sardinian ethanol-preferring rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Characterization of neurokinin receptors in various isolated organs by the use of selective agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Study of the clomipramine-morphine interaction in the forced swimming test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Brain tachykinins and the regulation of salt intake

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: New tools for investigating neurokinin function

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Naloxone blocks conditioned place preference induced by substance P and [pGlu6]-SP(6–11)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Endogenous opioid systems and alcohol addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

cDNA sequence and heterologous expression of the human neurokinin-3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurotransmitter regulation of dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neuroscience of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Analysis of tachykinin binding site interactions using constrained analogues of tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Localization of the tachykinin neurokinin B precursor peptide in rat brain by immunocytochemistry and in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The mammalian tachykinin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Tachykinin-induced changes in beta-endorphin gene expression in the rat arcuate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Distribution of neurons expressing neurokinin B in the rat brain: immunohistochemistry and in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Tachykinin receptor subtypes involved in the central effects of tachykinins on water and salt intake

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

[125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3 receptor in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Involvement of endogenous enkephalins in the mouse 'behavioral despair' test

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Two NK-3 receptor subtypes: demonstration by biological and binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Agonists selective for tachykinin NK1 and NK3 receptors excite subpopulations of neurons in the rat medial habenula nucleus in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Substance-P antagonists: a new treatment for depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurotransmitter functions of mammalian tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Ventral pallidum self-stimulation induces stimulus dependent increase in c-fos expression in reward-related brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Sensitivity of brain sites to the inhibitory effect on alcohol intake of the tachykinin aminosenktide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Differentiation of neurochemical basis of stress-induced analgesia in mice by selective breeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Effects of the selective tachykinin NK3 receptor agonist NH2-senktide on intraoral intake and taste reactivity responses elicited by NaCl in sodium-replete rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Application of taste reactivity to study the mechanism of alcohol intake inhibition by the tachykinin aminosenktide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Preprotachykinin-A gene expression in the forebrain of Sardinian alcohol-preferring and -nonpreferring rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Depression: a new animal model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Neurokinin receptor subtypes characterized by biological assays

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Characterization of NK-3 binding sites in rat and guinea pig cortical membranes by the selective ligand [3H]Senktide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Tachykinin NK(3)receptor involvement in anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Experimental immunohistochemical studies on the amygdalofugal peptidergic (substance P and somatostatin) fibers in the stria terminals of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Central action of substance P: possible role in reward

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Behavioural effects of selective tachykinin agonists in midbrain dopamine regions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Reward for persistence in substance P research.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Drug-activation of brain reward pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Highly selective agonists for substance P receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

NK3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900291-6

7 January 2021

10.1016/S0196-9781(00)00291-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11090913